Zhejiang Shengda Pharm (603079) — Cash Flow Quality Index
Zhejiang Shengda Pharm (603079) has a Cash Flow Quality Index of 2.91x as of September 2025. Operating cash flow of CN¥45.27 Million exceeds net income of CN¥15.53 Million, indicating high earnings quality where cash backs reported profits. Also explore 603079 total asset value for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Zhejiang Shengda Pharm Cash Flow Quality Index (2012–2025)
Historical Cash Flow Quality Index for Zhejiang Shengda Pharm across 13 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check how tangible is Zhejiang Shengda Pharm's equity to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Zhejiang Shengda Pharm (2012–2025)
Year-by-year earnings quality comparison for Zhejiang Shengda Pharm. For live market cap and the full company financial profile, see Zhejiang Shengda Pharm market cap and net worth.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.23x | CN¥138.88 Million | CN¥62.16 Million | ▼ -43.7% |
| 2024 | 3.97x | CN¥147.88 Million | CN¥37.26 Million | ▲ +196.7% |
| 2022 | 1.34x | CN¥40.72 Million | CN¥30.44 Million | ▲ +29.0% |
| 2021 | 1.04x | CN¥74.46 Million | CN¥71.82 Million | ▼ -40.9% |
| 2020 | 1.75x | CN¥333.20 Million | CN¥189.97 Million | ▲ +13.1% |
| 2019 | 1.55x | CN¥58.55 Million | CN¥37.76 Million | ▼ -25.5% |
| 2018 | 2.08x | CN¥88.69 Million | CN¥42.58 Million | ▲ +58.6% |
| 2017 | 1.31x | CN¥95.33 Million | CN¥72.61 Million | ▲ +9.6% |
| 2016 | 1.20x | CN¥73.00 Million | CN¥60.94 Million | ▼ -29.9% |
| 2015 | 1.71x | CN¥148.07 Million | CN¥86.70 Million | ▲ +117.4% |
| 2014 | 0.79x | CN¥34.40 Million | CN¥43.79 Million | ▼ -59.3% |
| 2013 | 1.93x | CN¥105.28 Million | CN¥54.59 Million | ▼ -8.3% |
| 2012 | 2.10x | CN¥110.08 Million | CN¥52.36 Million | — |